On April 26, 2024, West Pharmaceutical Services Inc announced that it held its annual general meeting of shareholders on April 23, 2024 and declared voting results. The Company stated that the shareholders voted on 5 proposals at the Annual Meeting. After the Proxy publication date, the U.S. Securities and Exchange Commission ("SEC") issued a No-Action Letter in the favor regarding the shareholder proposal included in the Proxy as Proposal 6. Therefore, a shareholder proposal is submitted by John Chevedden regarding simple majority vote was not presented at the 2024 Annual Shareholder Meeting, because it was duplicative of management Proposals 3 and 4. The proposals are described in detail in the proxy statement dated March 13, 2024.